News Center
-
Eric Tse Elected as a Council Member of the Yabuli China Entrepreneurs Forum: Restructuring Internally, Growing Externally, How Does SBP Group Achieve Counter-Cyclical Growth?
On September 5, the 22nd Summer Summit of the Yabuli China Entrepreneurs Forum (hereinafter referred to as Yabuli Forum) 2026 opened in Chengdu with the theme "Corporate Innovation and Overcoming Cycles".View -
SBP Group Named "Top Employer in China" 2026
Recently, Sino Biopharmaceutical Limited (SBP Group, 1177.HK) was awarded the "Top Employer in China" 2026 certification by the Top Employers Institute. SBP Group has always regarded talent as the core driving force for corporate development.View -
SBP Group Reaches Exclusive Licensing Agreement with Cipla, Bringing TQB2102 to 7 High-Growth International Markets
View -
SBP Group Named to the 2026 Pharm Exec Top 50 Companies for Eight Consecutive Years
Recently, the U.S. magazine Pharm Exec released its 2026 Pharm Exec Top 50 Companies, with Sino Biopharmaceutical Limited (SBP Group, 1177.HK) making the list for the 8th consecutive year.View
Science for a healthier world
